Collegium Announces Expanded Managed Care Coverage for Xtampza ER for Medicare Part D Patients by Carolyn Helms | Apr 3, 2017 | Portfolio News
Jazz Pharmaceuticals and Nippon Shinyaku Enter Into License Agreements for the Development and Commercialization of Defitelio and Vyxeos in Japan by Carolyn Helms | Mar 30, 2017 | Portfolio News
SutroVax Announces Closing of $64M via Series B Financing by Carolyn Helms | Mar 21, 2017 | Portfolio News
Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 3 and TONES 4 Studies of JZP-110 in Patients with Obstructive Sleep Apnea by Carolyn Helms | Mar 20, 2017 | Portfolio News
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Study Evaluating JZP-258 for the Treatment of Cataplexy and Excessive Daytime Sleepiness in Narcolepsy by Carolyn Helms | Mar 15, 2017 | Portfolio News
